Asensus Surgical, Inc.

AMEX:ASXC

0.2356 (USD) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993199219911990
Revenue 8.5777.0878.2323.1758.53124.1027.1111.51900.4011.4310.0350-000-0.1350000.23111.77120.41625.97310.21230.320.912.19.75.34.82.31.4
Cost of Revenue 13.60810.87211.0965.16620.73116.1716.7271.0692.1851.0954.810.382000000000.18211.55116.09920.5322.59.51614.73.22.71.92.10.82.6
Gross Profit -5.031-3.785-2.864-1.991-12.27.9310.3840.45-2.185-0.694-3.379-0.3470-000-0.1350000.0490.224.3175.4417.72.514.36.28.973.42.71.5-1.2
Gross Profit Ratio -0.587-0.534-0.348-0.627-1.430.3290.0540.2960-1.731-2.361-9.914010010000.2120.0190.2110.2090.7550.2080.4720.2970.7360.7220.6420.5630.652-0.857
Reseach & Development Expenses 37.02328.94219.34816.62122.46821.82321.98929.27329.66927.94412.72.9163.3672.7281.2562.6821.63600001.5221.8411.481.64.58.15.53.500000
General & Administrative Expenses 19.15520.17219.32314.13718.75813.85412.27510.8137.8316.2444.2212.7630000000000000000000000
Selling & Marketing Expenses 16.92114.75613.39513.06428.01425.73617.5369.1512.8551.7271.9433.7230000000000000000000000
SG&A 36.07634.92832.71827.20146.77239.5929.81119.96410.6867.9716.1643.3922.3062.6171.3991.6521.1350.3710.3180.4731.1182.4033.1583.4362.83.58.26.44.24.73.63.52.40
Other Expenses -1.4367.70811.25410.80110.3011.126-0.30.0352.18507.72100000000000001.24.93.21.91.6110.80.40.4
Operating Expenses 73.09971.57863.3254.62379.54172.28159.65856.20442.5435.91518.8646.3085.6735.3452.6554.3342.7710.3710.3180.4731.1183.9254.9994.9165.612.919.513.89.35.74.64.32.80.4
Operating Income -78.13-75.679-64.619-60.389-154.575-49.152-61.927-123.649-46.371-36.609-25.604-6.655-5.673-5.345-2.655-4.334-2.771-0.371-0.318-0.473-1.069-3.705-0.6820.5252.1-10.4-5.2-7.6-0.41.3-1.2-1.6-1.3-1.6
Operating Income Ratio -9.109-10.679-7.85-19.02-18.119-2.039-8.709-81.4020-91.294-17.892-190.1430184,3100020.526000-4.628-0.315-0.0330.020.206-0.867-0.172-0.364-0.0330.134-0.226-0.333-0.565-1.143
Total Other Income Expenses Net 0.0110.4362.382-0.439-2.752.004-86.06-67.86-3.831-1.043-5.161-0.069-0.0370.040.308-0.851-0.270.0010.090.0290.046-1.7540.9741.6690.3-0.40.20.30.50.300.20.30
Income Before Tax -78.119-75.243-62.237-60.828-157.325-65.154-148.096-125.503-47.972-37.652-28.358-6.724-5.758-0.005-2.366-5.185-3.041-0.204-0.228-0.444-0.966-5.3820.62.612.4-10.8-5-7.30.11.60-1.4-10
Income Before Tax Ratio -9.108-10.617-7.56-19.158-18.442-2.703-20.826-82.6220-93.895-19.817-192.1140182.8620022.526000-4.182-0.4570.0290.10.235-0.9-0.165-0.3490.0080.1650-0.292-0.4350
Income Tax Expense 0.3140.3180.225-1.516-3.124-3.377-3.3-5.523-1.02404.632-0.0140.048-0.0420.019-0.8270-0.166000.001-0.006-0.0110.058-0.50.5-0.2-0.2-0.5-0.20-0.1-0.30
Net Income -78.433-75.561-62.462-59.312-154.201-61.777-144.796-119.98-46.948-37.652-28.358-6.724-5.758-5.303-2.366-5.185-3.041-0.204-0.228-0.444-0.967-5.4760.6112.5522.6-10.9-5-7.40.11.5-1.2-1.5-1-1.6
Net Income Ratio -9.145-10.662-7.588-18.681-18.075-2.563-20.362-78.9860-93.895-19.817-192.1140182,8620022.526000-4.186-0.4650.030.0980.255-0.908-0.165-0.3540.0080.155-0.226-0.313-0.435-1.143
EPS -0.31-0.32-0.28-0.84-8.69-3.88-0.97-1.07-0.59-0.64-2.23-6.24-1.03-1.19-0.66-1.51-1.19-0.064-0.3-0.9-2.11-11.951.355.65.7-23.89-11.1-16.820.234-3.5-5-51.59-6.5
EPS Diluted -0.31-0.32-0.28-0.84-8.69-3.88-0.97-1.07-0.59-0.64-2.23-6.24-1.03-1.19-0.66-1.51-1.19-0.064-0.3-0.9-2.11-11.951.355.455.65-23.89-11.1-16.820.233.5-3.5-5-51.59-6.5
EBITDA -74.401-63.441-50.187-42.999-79.659-48.53636.8321.05-35.276-35.299-17.082-6.502-5.533-5.298-2.599-5.106-2.484-0.372-0.318-0.473-0.986-1.614-1.082-0.453-5.1-2.2-60.72-0.2-1-1.2-1.2
EBITDA Ratio -8.674-8.952-6.097-13.543-9.338-2.0145.17913.8580-88.027-11.937-185.7710182,6890018.4000-4.268-0.137-0.053-0.0170.294-0.425-0.073-0.2870.0580.206-0.038-0.208-0.522-0.857